Aspen Aerogels, Inc. (NYSE:ASPN) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of Aspen Aerogels, Inc. (NYSE:ASPN) have earned a consensus recommendation of “Hold” from the seven research firms that are currently covering the company, Marketbeat reports. Two analysts have rated the stock with a sell rating, one has given a hold rating and four have given a buy rating to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $5.9375.

A number of equities research analysts recently weighed in on the company. Wall Street Zen cut Aspen Aerogels from a “hold” rating to a “sell” rating in a report on Saturday. Weiss Ratings reiterated a “sell (d-)” rating on shares of Aspen Aerogels in a research report on Wednesday, June 24th. Barclays raised their price target on Aspen Aerogels from $4.00 to $5.00 and gave the company an “underweight” rating in a research report on Tuesday, August 11th. Roth Capital reaffirmed a “buy” rating and set a $7.75 price target on shares of Aspen Aerogels in a research note on Friday, August 7th. Finally, B. Riley Financial restated a “buy” rating on shares of Aspen Aerogels in a report on Friday, August 7th.

Aspen Aerogels Stock Performance

Shares of ASPN opened at $5.83 on Tuesday. The company has a quick ratio of 2.24, a current ratio of 2.52 and a debt-to-equity ratio of 0.36. Aspen Aerogels has a 52-week low of $2.30 and a 52-week high of $9.35. The company has a 50-day simple moving average of $5.52 and a 200-day simple moving average of $4.53. The company has a market capitalization of $483.83 million, a PE ratio of -3.81 and a beta of 2.99.

Aspen Aerogels (NYSE:ASPN) last released its quarterly earnings data on Thursday, August 6th. The construction company reported ($0.22) EPS for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.01. Aspen Aerogels had a negative net margin of 62.45% and a negative return on equity of 31.12%. The firm had revenue of $49.85 million for the quarter, compared to the consensus estimate of $42.42 million. Aspen Aerogels has set its Q3 2026 guidance at -0.110–0.070 EPS. Equities research analysts predict that Aspen Aerogels will post -0.69 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of ASPN. Royal Bank of Canada increased its position in Aspen Aerogels by 95.8% during the first quarter. Royal Bank of Canada now owns 8,523 shares of the construction company’s stock worth $29,000 after buying an additional 4,169 shares in the last quarter. Drive Wealth Management LLC acquired a new stake in shares of Aspen Aerogels during the fourth quarter valued at $30,000. Caitong International Asset Management Co. Ltd purchased a new stake in Aspen Aerogels during the 4th quarter worth about $30,000. Clarus Group Inc. acquired a new position in Aspen Aerogels in the 1st quarter valued at about $36,000. Finally, WINTON GROUP Ltd acquired a new position in Aspen Aerogels in the 4th quarter valued at about $40,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.